140 related articles for article (PubMed ID: 37683054)
21. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
Front Oncol; 2019; 9():1456. PubMed ID: 31998635
[No Abstract] [Full Text] [Related]
22. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
23. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
[TBL] [Abstract][Full Text] [Related]
24. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated proton therapy decreases dose to organs at risk in low-grade glioma patients: results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Cubillos-Mesías M; Niël C; Smeenk RJ; Hoeben A; Minken AWH; Granzier M; Janssens GO; Kaanders JHAM; Lambin P; Troost EGC
Acta Oncol; 2019 Jan; 58(1):57-65. PubMed ID: 30474448
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies.
Milby AB; Both S; Ingram M; Lin LL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e477-84. PubMed ID: 22177626
[TBL] [Abstract][Full Text] [Related]
27. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
[TBL] [Abstract][Full Text] [Related]
28. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
Taggar AS; Graham D; Kurien E; Gräfe JL
J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585
[TBL] [Abstract][Full Text] [Related]
29. In silico comparison of whole pelvis intensity-modulated photon versus proton therapy for the postoperative management of prostate cancer.
Gogineni E; Cruickshank IK; Chen H; Halthore A; Li H; Deville C
Acta Oncol; 2023 Jun; 62(6):642-647. PubMed ID: 37345868
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric comparison of two treatment planning systems for spine SBRT.
Lee YK; Munawar I; Mashouf S; Sahgal A; Ruschin M
Med Dosim; 2020 Spring; 45(1):77-84. PubMed ID: 31376988
[TBL] [Abstract][Full Text] [Related]
31. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
[TBL] [Abstract][Full Text] [Related]
32. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
33. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
[TBL] [Abstract][Full Text] [Related]
34. Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy.
Loap P; Orlandi E; De Marzi L; Vitolo V; Barcellini A; Iannalfi A; Dendale R; Kirova Y; Mirandola A
Acta Oncol; 2022 Aug; 61(8):979-986. PubMed ID: 35668710
[TBL] [Abstract][Full Text] [Related]
35. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
37. Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture.
Su Z; Indelicato DJ; Mailhot RB; Bradley JA
J Appl Clin Med Phys; 2020 Jun; 21(6):100-107. PubMed ID: 32268008
[TBL] [Abstract][Full Text] [Related]
38. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
39. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
40. The feasibility of dose escalation using intensity-modulated radiotherapy (IMRT) and intensity-modulated proton therapy (IMPT) with FDG PET/CT guided in esophageal cancer.
Zhang Y; Fan B; Sun T; Xu J; Yin Y; Chen Z; Zhu J; Yu J; Hu M
J Cancer Res Ther; 2022 Sep; 18(5):1261-1267. PubMed ID: 36204871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
